Neutropenia: Difference between revisions
Rim Halaby (talk | contribs) No edit summary |
No edit summary |
||
| (32 intermediate revisions by 5 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ Neutropenia }} | {{ Neutropenia }} | ||
{{CMG}}; Aric Hall, M.D. Beth Israel Deaconess Medical Center, Boston, MA[mailto:achall@bidmc.harvard.edu] {{AE}}{{DG}}, {{Faizan}} | |||
{{SK}} Agranulocytosis, agranulosis, benign familial neutropenia, granulocytopenia, granulopenia, neutropaenia, neutrophilic leukopenia, neutrophilic leukocytopenia, neutrophilic leucopenia, neutrophilic leucocytopenia | {{SK}} Agranulocytosis, agranulosis, benign familial neutropenia, chronic benign neutropenia, cyclic neutropenia, CN, cyclic hematopoiesis, granulocytopenia, granulopenia, human cyclic neutropenia, neutropaenia, neutrophilic leukopenia, neutrophilic leukocytopenia, neutrophilic leucopenia, neutrophilic leucocytopenia | ||
Neutropenia is defined absolute neutrophil count < 1.5 x 10<sup>9</sup>/L. | |||
Agranulocytosis is defined as severe neutropenia < 0.5 x 10<sup>9</sup>/L. | |||
Although agranulocytosis and granulocytopenia should include reduced numbers of all granulocytes (either neutrophils, eosinophils, or basophils), the majority of cases of granulocytopenia are actually neutropenia since neutrophils constitute the majority of leukocytes; the term granulocytopenia almost always refers to deficient neutrophils. To read about eosinophilic leukopenia and basophilic leukopenia, click [[leukopenia|here]]. | |||
==[[Neutropenia overview|Overview]]== | ==[[Neutropenia overview|Overview]]== | ||
| Line 30: | Line 25: | ||
==[[Neutropenia epidemiology and demographics|Epidemiology and Demographics]]== | ==[[Neutropenia epidemiology and demographics|Epidemiology and Demographics]]== | ||
==[[Neutropenia risk factors|Risk Factors]]== | ==[[Neutropenia risk factors|Risk Factors]]== | ||
==[[Neutropenia screening|Screening]]== | ==[[Neutropenia screening|Screening]]== | ||
==[[Neutropenia natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | ==[[Neutropenia natural history, complications and prognosis|Natural History, Complications, and Prognosis]]== | ||
==Diagnosis== | ==Diagnosis== | ||
[[Neutropenia history and symptoms| History and Symptoms]] | [[Neutropenia physical examination | Physical Examination]] |[[Neutropenia laboratory findings|Laboratory Findings]] | [[Neutropenia chest x ray| | [[Neutropenia history and symptoms|History and Symptoms]] | [[Neutropenia physical examination|Physical Examination]] | [[Neutropenia laboratory findings|Laboratory Findings]] | [[Neutropenia chest x ray|X Ray]] | [[Neutropenia CT|CT]] | [[Neutropenia MRI|MRI]] | [[Neutropenia ultrasound|Ultrasound]] | [[Neutropenia other imaging findings|Other Imaging Findings]] | [[Neutropenia other diagnostic studies|Other Diagnostic Studies]] | ||
==Treatment== | ==Treatment== | ||
[[Neutropenia medical therapy|Medical Therapy]] | [[Neutropenia surgery|Surgery]] | [[Neutropenia primary prevention|Primary Prevention]] | [[Neutropenia secondary prevention|Secondary Prevention]] | [[Neutropenia cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Neutropenia future or investigational therapies|Future or Investigational Therapies]] | [[Neutropenia medical therapy|Medical Therapy]] | [[Neutropenia surgery|Surgery]] | [[Neutropenia primary prevention|Primary Prevention]] | [[Neutropenia secondary prevention|Secondary Prevention]] | [[Neutropenia cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Neutropenia future or investigational therapies|Future or Investigational Therapies]] | ||
{{Hematology}} | {{Hematology}} | ||
Latest revision as of 16:46, 24 October 2016
|
Neutropenia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Neutropenia On the Web |
|
American Roentgen Ray Society Images of Neutropenia |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Aric Hall, M.D. Beth Israel Deaconess Medical Center, Boston, MA[2] Associate Editor(s)-in-Chief: Daniel A. Gerber, M.D. [3], Faizan Sheraz, M.D. [4]
Synonyms and keywords: Agranulocytosis, agranulosis, benign familial neutropenia, chronic benign neutropenia, cyclic neutropenia, CN, cyclic hematopoiesis, granulocytopenia, granulopenia, human cyclic neutropenia, neutropaenia, neutrophilic leukopenia, neutrophilic leukocytopenia, neutrophilic leucopenia, neutrophilic leucocytopenia
Neutropenia is defined absolute neutrophil count < 1.5 x 109/L.
Agranulocytosis is defined as severe neutropenia < 0.5 x 109/L.
Although agranulocytosis and granulocytopenia should include reduced numbers of all granulocytes (either neutrophils, eosinophils, or basophils), the majority of cases of granulocytopenia are actually neutropenia since neutrophils constitute the majority of leukocytes; the term granulocytopenia almost always refers to deficient neutrophils. To read about eosinophilic leukopenia and basophilic leukopenia, click here.
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Neutropenia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications, and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | X Ray | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies